Leroy Hood: Getting past disease to the science of wellness
wctrib.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wctrib.com Daily Mail and Mail on Sunday newspapers.
Second Opinion: Getting past disease to the science of wellness
latimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latimes.com Daily Mail and Mail on Sunday newspapers.
Day One highlights
Microbiome through life: Exploring new science and commercial strategies from the first 1,000 days to healthy aging. The day features Francesco Asnicar, University of Trento; John Deaton, Deerland Probiotics & Enzymes; Jennifer Gu, AIDP, Inc; Lindsay Hall, Quadram Institute and the Technical University of Munich; David Kyle, Evolve BioSystems, Inc.; Stephen Lindemann, Purdue University and Nathan Price, Institute for Systems Biology and Onegevity Health.
Day Two will look at
New opportunities and developing ideas in the science and business of the microbiome and will feature experts such as Mariette Abrahams, Qina; Charles Budinoff, IFF; Noah Voreades, GenBiome Consulting; Paul Wilmes, Luxembourg Centre for Systems Biomedicine; Mark Wright, Health Wright Products and Hariom Yadav, Wake Forest University
Novel method can improve the detection of circulating tumor cells
Non-Small Cell Lung Cancer (NSCLC) is the most prevalent form of lung cancer, accounting for more than 80 percent of all lung cancer cases. Despite the aggressive nature of NSCLC, circulating tumor cells that lead to metastases often go undetected in the blood compared to breast, prostate, colorectal, and other cancers.
Now, scientists have developed a novel method to better detect the circulating tumor cells (CTCs) that are a telltale sign of metastases. The research was published in the journal
Proceedings of the National Academy of Sciences (
PNAS).
ISB and a collaborative team of researchers looked at hexokinase-2, or HK2, a key enzyme in glucose metabolism. A set of previous reports from our collaborator Dr. Herschman (co-author of the paper) and others revealed that cancer cells often rely on HK2 to elevate glucose metabolism to fuel their uncontrolled growth, making this enzyme a desirable target for test